|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,150.00 TWD | -2.54% |
|
-8.73% | +171.42% |
| 07-22 | PharmaEssentia Seeks Macau Nod to Expand Besremi Use for Rare Blood Cancer | MT |
| 07-09 | PharmaEssentia Swings to Profit in May as Revenue Balloons 108% | MT |
| Market Cap | 474B 14.64B 12.88B 11.96B 11B 20.63B 1,418B 21B 143B 55.8B 692B 54.97B 53.78B 2,399B | P/E 2026 * |
44.2x | P/E 2027 * | 32.1x |
|---|---|---|---|---|---|
| Enterprise Value | 448B 13.82B 12.16B 11.29B 10.39B 19.48B 1,339B 19.83B 135B 52.68B 653B 51.89B 50.77B 2,265B | EV / Sales 2026 * |
17.9x | EV / Sales 2027 * | 12.7x |
| Free-Float |
75.37% | Yield 2026 * |
0.08% | Yield 2027 * | 0.13% |
| 1 day | -2.54% | ||
| 1 week | -8.73% | ||
| Current month | -4.80% | ||
| 1 month | +16.50% | ||
| 3 months | +102.81% | ||
| 6 months | +112.61% | ||
| Current year | +171.42% |
| 1 week | 1,125 |  | 1,235 |
| 1 month | 1,032.2 | | 1,415.34 |
| Current year | 423.7 | | 1,415.34 |
| 1 year | 395.61 | | 1,415.34 |
| 3 years | 222.58 | | 1,415.34 |
| 5 years | 56.05 | | 1,415.34 |
| 10 years | 43.54 | | 1,415.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2003 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Albert Qin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ching Liu Chan
CHM | Chairman | - | 01/09/2003 |
Cheng Ku Huang
BRD | Director/Board Member | - | - |
Chao Ho Chen
BRD | Director/Board Member | - | 30/06/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.54% | -8.73% | +164.11% | +289.45% | 15B | |
| +1.23% | +0.35% | +51.62% | +87.98% | 55.27B | |
| +5.09% | +6.24% | +63.15% | +62.06% | 54.15B | |
| +0.72% | -0.05% | +3.84% | +409.54% | 23.11B | |
| +0.25% | +0.55% | -19.67% | -15.22% | 23.22B | |
| +1.03% | -0.20% | +36.49% | -3.59% | 20.33B | |
| -0.37% | +0.71% | +31.36% | -31.61% | 17.91B | |
| +0.87% | -0.19% | +39.07% | +600.00% | 15.76B | |
| +1.22% | -0.05% | +22.58% | +182.63% | 13.82B | |
| +1.06% | -0.40% | +77.13% | +151.84% | 12.4B | |
| Average | +0.86% | +0.60% | +46.97% | +173.31% | 25.1B | |
| Weighted average by Cap. | +1.54% | +2.62% | +46.03% | +139.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.07B 774M 681M 633M 582M 1.09B 74.98B 1.11B 7.56B 2.95B 36.57B 2.91B 2.84B 127B | 34.57B 1.07B 939M 872M 802M 1.5B 103B 1.53B 10.43B 4.07B 50.43B 4.01B 3.92B 175B |
| Net income | 10.85B 335M 295M 274M 252M 472M 32.46B 481M 3.28B 1.28B 15.83B 1.26B 1.23B 54.94B | 14.97B 462M 407M 378M 347M 652M 44.78B 663M 4.52B 1.76B 21.84B 1.74B 1.7B 75.77B |
| Net Debt | -26.52B -819M -720M -669M -616M -1.15B -79.33B -1.18B -8B -3.12B -38.7B -3.08B -3.01B -134B | -34.73B -1.07B -943M -876M -806M -1.51B -104B -1.54B -10.48B -4.09B -50.66B -4.03B -3.94B -176B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | NT$1,150.00 | -2.54% | 2,928,191 |
| 22/07/26 | NT$1,180.00 | +0.43% | 2,030,357 |
| 21/07/26 | NT$1,175.00 | 0.00% | 2,044,851 |
| 20/07/26 | NT$1,175.00 | -1.67% | 2,926,691 |
| 17/07/26 | NT$1,195.00 | -5.16% | 3,377,763 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
Select your edition
All financial news and data tailored to specific country editions
